Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 13;11(12):3390.
doi: 10.3390/jcm11123390.

Development of New Mental and Physical Health Sequelae among US Veterans after COVID-19

Affiliations

Development of New Mental and Physical Health Sequelae among US Veterans after COVID-19

Nilang Patel et al. J Clin Med. .

Abstract

Background:COVID-19 sequelae among veterans need evaluation. Design: Propensity-score-matched retrospective cohort study. Participants: A total 778,738 veterans, who were tested for COVID-19 at VA facilities between 20 February 2020−27 March 2021. Main Outcomes: Development of new physical and mental health conditions (incidence) during the follow-up period of 7 days to 3 months after the diagnosis of COVID-19. Results: Out of 778,738 veterans, 149,205 (19.2%) were inpatients and 629,533 (80.8%) were outpatients. 123,757 (15.9%) diagnosed with COVID-19. Mean age was 61 ± 15.4, mostly men (89%) who were White (68%) and non-Hispanic (88%). In hospitalized patients, COVID-19 is associated with significantly higher incidences of physical conditions (venous thromboembolism (5.8% vs. 2.9%, p < 0.001), pulmonary circulation disorder (5.1% vs. 2.9%, p < 0.001), chronic lung disease (8.4% vs. 4.3%, p < 0.001), acute kidney injury (16.4% vs. 9.3%, p < 0.001), chronic kidney disease (6.5% vs. 4.8%, p < 0.001), cardiac arrhythmia (15.2% vs. 10.9%, p < 0.001), complicated hypertension (12% vs. 8.5%, p < 0.001), coagulopathy (6.1% vs. 2.6%, p < 0.001), fluid/electrolyte disorders (24.4% vs. 12.6%, p < 0.001) and neurological disorders (7.1% vs. 3.8%, p < 0.001)) and mental health conditions (depressive episode (6.6% vs. 4.3%, p < 0.001), adjustment disorder (2.5% vs. 1.7%, p < 0.001), insomnia (4.9% vs. 3.2%, p < 0.001) and dementia (3.0% vs. 1.9%, p < 0.001)) compared to propensity-matched hospitalized COVID-19 negative patients. In outpatient settings, COVID-19 diagnosis is associated with smaller increase in the incidences of the physical sequelae. Conclusions: In this propensity-score-matched analysis of US veterans, COVID-19 survivors, especially those who were hospitalized, developed new physical and mental health sequelae at a significantly higher rate than those without COVID-19.

Keywords: COVID-19; mental sequelae; physical sequelae; veterans.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart.
Figure 2
Figure 2
Likelihood of development of new physical and mental health conditions in COVID-19-positive patients compared to COVID-19-negative patients. The figure (a) represents the odds ratio for the development of new physical and mental health conditions among propensity-score-matched hospitalized COVID-19 positive patients versus hospitalized COVID-19-negative patients during the follow-up period of 7 days to 3 months of diagnosis. For example—COVID-19-positive patients are 1.4 times (OR: 1.4, 95% CI 1.2–1.6) more likely to develop chronic kidney disease than COVID-19-negative patients during the follow-up period of 7 days to 3 months of diagnosis. The figure (b) represents the odds ratio for the development of new physical and mental health conditions among matched outpatient COVID-19-positive patients versus outpatient COVID-19-negative patients.

Similar articles

Cited by

References

    1. Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220–232. doi: 10.1016/S0140-6736(20)32656-8. - DOI - PMC - PubMed
    1. Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X. - DOI - PMC - PubMed
    1. Fisicaro F., Di Napoli M., Liberto A., Fanella M., Di Stasio F., Pennisi M., Bella R., Lanza G., Mansueto G. Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective. Int. J. Environ. Res. Public Health. 2021;18:1415. doi: 10.3390/ijerph18041415. - DOI - PMC - PubMed
    1. Tan B.-H., Liu J.-M., Gui Y., Wu S., Suo J.-L., Li Y.-C. Neurological involvement in the respiratory manifestations of COVID-19 patients. Aging. 2021;13:4713–4730. doi: 10.18632/aging.202665. - DOI - PMC - PubMed
    1. Roshdy A., Zaher S., Fayed H., Coghlan J.G. COVID-19 and the Heart: A Systematic Review of Cardiac Autopsies. Front. Cardiovasc. Med. 2020;7:626975. doi: 10.3389/fcvm.2020.626975. - DOI - PMC - PubMed

LinkOut - more resources